CellSearch (2009 Prix Galien USA Winner)

CellSearch from Johnson & Johnson's Janssen Diagnostics is the first and only actionable test for detecting circulating tumor cells in cancer patients. Detecting such CTCs is important because their presence indicates decreased odds of survival for metastatic breast, colorectal, or prostate cancer patients, according to Janssen. The tests, then, are an important new tool in the toolbox in the fight against cancer. 

The 10 Most Promising Medical Technologies of 2016 >>

And vote in our survey >>

[Image courtesy of Janssen Diagnostics]